{"uri":"cultivation-of-plasmodium-falciparum-in-serum-free-i36cgre","version_id":"1","protocol_name":"Cultivation of Plasmodium falciparum in serum-free media with growth-promoting factor from bovine plasma (GFS)","protocol_name_html":"Cultivation of Plasmodium falciparum in serum-free media with growth-promoting factor from bovine plasma (GFS)","is_prepublished":"0","can_edit":"0","parent_id":"6925","api_version":"1","is_new_mode":"0","last_modified":"1520316661","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0184874","fork_id":"","public_fork_note":null,"number_of_steps":"3","has_versions":"1","first_published_date":"1500851804","publish_date":"2017-09-22 18:07:17","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":null,"is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"6925","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1500850729","protocol_affiliation":"","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.i36cgre","doi_status":"2","changed_fork_steps":null,"profile_url":"x2134433q2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/014.png","full_name":"Hiroko Asahi","created_by":"Hiroko Asahi","private_link":"704CBA201B323EA0B72B17F847A97D01","original_img":"1","username":"hiroko-asahi","is_retracted":"0","retraction_reason":null,"plos_id":null,"manuscript_citation":"Asahi H,  Inoue S,  Niikura M,  Kunigo K,  Suzuki Y,  Kobayashi F,  Sendo F (2017) Profiling molecular factors associated with pyknosis and developmental arrest induced by an opioid receptor antagonist and dihydroartemisinin in <i>Plasmodium falciparum<\/i>. PLoS ONE  12(9): e0184874. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0184874\">10.1371\/journal.pone.0184874<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":254598,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"","authors_list":[],"user":{"profile_image":"\/img\/avatars\/014.png","username":"hiroko-asahi","full_name":"Hiroko Asahi","created_by":"Hiroko Asahi"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"580298","is_changed":"0","original_id":"579803","is_skipped":"0","is_checked":"0","guid":"F7E31B6D2C124F599A0579BCE840C075","previous_guid":null,"previous_id":null,"last_modified":"1500851769","components":[{"component_id":"963702","previous_id":0,"original_id":"962580","guid":"763E93A3FFAF452DAD245C41CDDF7B5D","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p><strong>step 1<\/strong><\/p>\n<p><strong>The composition of media: <\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<ol>\n<li>Complete culture medium (GFSRPMI):<\/li>\n<\/ol>\n<p>Mix the following constituents aseptically.<\/p>\n<p>(1) 900ml RPMI1640 (with L-Glutamine, with 25mM HEPES, w\/o NaHCO<sub>3<\/sub>)*<\/p>\n<p>(2) 100ml GFS: GF21 (Wako Pure Chemical Industries, Osaka, Japan)<\/p>\n<p>(3) 2 g (24 mM) sodium bicarbonate (Invitrogen Ltd.)<\/p>\n<p>(4) 25mg gentamycin (Sigma-Aldrich Corp., St. Lowis, MO, USA)<\/p>\n<p>(5) 20 mg (150 \u00b5M) hypoxanthine (Sigma-Aldrich)**<\/p>\n<p>\u00a0<\/p>\n<p>*gibco ref. 22400 (Invitrogen Ltd., Carlsbad, CA, USA)<\/p>\n<p>**1.5 ml aliquot of 10 mM solution is added to 100 ml culture medium when using the medium.<\/p>\n<p>\u00a0<\/p>\n<ol start=\"2\">\n<li>Basal medium: Mix the following constituents aseptically.<\/li>\n<\/ol>\n<p>(1) 1000ml RPMI1640 (with L-Glutamine, with 25mM HEPES, w\/o NaHCO<sub>3<\/sub>)<\/p>\n<p>(2) 25mg gentamycin (Sigma-Aldrich)<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p><strong>step 1<\/strong><\/p>\n<p><strong>The composition of media: <\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<ol>\n<li>Complete culture medium (GFSRPMI):<\/li>\n<\/ol>\n<p>Mix the following constituents aseptically.<\/p>\n<p>(1) 900ml RPMI1640 (with L-Glutamine, with 25mM HEPES, w\/o NaHCO<sub>3<\/sub>)*<\/p>\n<p>(2) 100ml GFS: GF21 (Wako Pure Chemical Industries, Osaka, Japan)<\/p>\n<p>(3) 2 g (24 mM) sodium bicarbonate (Invitrogen Ltd.)<\/p>\n<p>(4) 25mg gentamycin (Sigma-Aldrich Corp., St. Lowis, MO, USA)<\/p>\n<p>(5) 20 mg (150 \u00b5M) hypoxanthine (Sigma-Aldrich)**<\/p>\n<p>\u00a0<\/p>\n<p>*gibco ref. 22400 (Invitrogen Ltd., Carlsbad, CA, USA)<\/p>\n<p>**1.5 ml aliquot of 10 mM solution is added to 100 ml culture medium when using the medium.<\/p>\n<p>\u00a0<\/p>\n<ol start=\"2\">\n<li>Basal medium: Mix the following constituents aseptically.<\/li>\n<\/ol>\n<p>(1) 1000ml RPMI1640 (with L-Glutamine, with 25mM HEPES, w\/o NaHCO<sub>3<\/sub>)<\/p>\n<p>(2) 25mg gentamycin (Sigma-Aldrich)<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"963703","previous_id":"963702","original_id":"962581","guid":"5C82777251ED44D28CAA7B8DCAC97164","previous_guid":"763E93A3FFAF452DAD245C41CDDF7B5D","component_type_id":"6","data_id":null,"data":"","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0}]},{"id":"580299","is_changed":"0","original_id":"580286","is_skipped":"0","is_checked":"0","guid":"C472BC51D291477DB0178C4E0AB82A9F","previous_guid":"F7E31B6D2C124F599A0579BCE840C075","previous_id":"580298","last_modified":"1500850729","components":[{"component_id":"963704","previous_id":0,"original_id":"963678","guid":"971F03A634844F46A0E66E5AD4185028","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p><strong>Step 2 <\/strong><\/p>\n<p><strong>Start cultures of <em>Plasmodium falciparum<\/em><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<ol>\n<li>Preserve erythrocytes (RBCs) in Alsever\u2019s solution* at 4 \u00b0C for 3\u2013 30 days.<\/li>\n<li>Wash RBCs by centrifugation for 10 min at 800g, admixed with RBCs infected with <em>Plasmodium falciparum<\/em> (PfRBCs), dispense into 24-well culture plates at a hematocrit of 2% (1 ml of suspension\/well), and culture in a humidified atmosphere of 5%CO<sub>2<\/sub>, 5% O<sub>2<\/sub>, and 90% N<sub>2<\/sub> at 37\u00b0C.<\/li>\n<li>Adjust the parasitemia to 0.1% (for subculture) or 0.3%(for growth tests) by adding uninfected RBCs, and the hematocrit to 2% by adding the appropriate volume of culture medium.<\/li>\n<\/ol>\n<p><strong>\u00a0<\/strong><\/p>\n<p>*Alsever\u2019s solution:<\/p>\n<ol>\n<li>Solubilize the following constituents in 200 ml distilled water.<\/li>\n<\/ol>\n<p>Autoclave the mixture and add to whole blood or RBCs at 1:1 to 1:4. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (1) Glucose\u00a0\u00a0 4.1g<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (2) NaCl\u00a0\u00a0 0.84g<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (3) Na<sub>3 <\/sub>citrate.2H<sub>2<\/sub>O\u00a0\u00a0\u00a0\u00a0 1.6g<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (4) Citric acid\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0.11g<\/p>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p><strong>Step 2 <\/strong><\/p>\n<p><strong>Start cultures of <em>Plasmodium falciparum<\/em><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<ol>\n<li>Preserve erythrocytes (RBCs) in Alsever\u2019s solution* at 4 \u00b0C for 3\u2013 30 days.<\/li>\n<li>Wash RBCs by centrifugation for 10 min at 800g, admixed with RBCs infected with <em>Plasmodium falciparum<\/em> (PfRBCs), dispense into 24-well culture plates at a hematocrit of 2% (1 ml of suspension\/well), and culture in a humidified atmosphere of 5%CO<sub>2<\/sub>, 5% O<sub>2<\/sub>, and 90% N<sub>2<\/sub> at 37\u00b0C.<\/li>\n<li>Adjust the parasitemia to 0.1% (for subculture) or 0.3%(for growth tests) by adding uninfected RBCs, and the hematocrit to 2% by adding the appropriate volume of culture medium.<\/li>\n<\/ol>\n<p><strong>\u00a0<\/strong><\/p>\n<p>*Alsever\u2019s solution:<\/p>\n<ol>\n<li>Solubilize the following constituents in 200 ml distilled water.<\/li>\n<\/ol>\n<p>Autoclave the mixture and add to whole blood or RBCs at 1:1 to 1:4. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (1) Glucose\u00a0\u00a0 4.1g<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (2) NaCl\u00a0\u00a0 0.84g<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (3) Na<sub>3 <\/sub>citrate.2H<sub>2<\/sub>O\u00a0\u00a0\u00a0\u00a0 1.6g<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0 (4) Citric acid\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0.11g<\/p>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"963705","previous_id":"963704","original_id":"963679","guid":"7B4CF4BC1C7547658F62CE92A5ED8090","previous_guid":"971F03A634844F46A0E66E5AD4185028","component_type_id":"6","data_id":null,"data":"","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0}]},{"id":"580300","is_changed":"0","original_id":"580288","is_skipped":"0","is_checked":"0","guid":"EA6CB40521E14F61B89DF4AF8772E05E","previous_guid":"C472BC51D291477DB0178C4E0AB82A9F","previous_id":"580299","last_modified":"1500850729","components":[{"component_id":"963706","previous_id":0,"original_id":"963682","guid":"D5C7FA7EB119417A996BB9B06F33ED83","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p><strong>step 3<\/strong><\/p>\n<p><strong>Preparation of highly, synchronized cultures at the ring stage:<\/strong><\/p>\n<p>The cultures of <em>Plasmodium falciparum<\/em> are synchronized at the ring stage by three successive exposures to 5% D-sorbitol.<\/p>\n<p>\u00a0<\/p>\n<ol>\n<li>Expose asynchronous PfRBCs to 5% (w\/v) D-sorbitol (Sigma-Aldrich) for 5 min.<\/li>\n<li>After washing with basal medium by centrifugation for 6 min at 500g, adjust the parasitemia to 0.8%\u20131.2% by adding uninfected RBCs, dispense into 24-well culture plates at a hematocrit of 2%, and cultured for 41 h.<\/li>\n<li>At 41-h culture, expose the PfRBCs to 5% D-sorbitol (the 2nd exposure), wash, and culture for further 5 h.<\/li>\n<li>At the total 46-h culture, expose the PfRBCs to 5% D-sorbitol (the 3rd exposure).<\/li>\n<li>After the 3rd sorbitol treatment, remove residual schizonts and cell debris by isopycnic density centrifugation for 10 min at 800g on 63% Percoll PLUS* (GE Healthcare Bio-Science Corp., Tokyo, Japan).<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<p>*3.5 ml 90% Percoll PLUS + 1.5 ml PBS<\/p>\n<p>90% Percoll PLUS is prepared by admixing 100% Percoll PLUS (9 parts) with 1.5 M NaCl (10x physiological saline) (1 part).<\/p>\n<p>\u00a0<\/p>\n<p><strong>Note:<\/strong> Periods for growth to the schizont stage are somewhat variable among strains. Culture periods useful for the protocol should be confirmed beforehand. <\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p><strong>step 3<\/strong><\/p>\n<p><strong>Preparation of highly, synchronized cultures at the ring stage:<\/strong><\/p>\n<p>The cultures of <em>Plasmodium falciparum<\/em> are synchronized at the ring stage by three successive exposures to 5% D-sorbitol.<\/p>\n<p>\u00a0<\/p>\n<ol>\n<li>Expose asynchronous PfRBCs to 5% (w\/v) D-sorbitol (Sigma-Aldrich) for 5 min.<\/li>\n<li>After washing with basal medium by centrifugation for 6 min at 500g, adjust the parasitemia to 0.8%\u20131.2% by adding uninfected RBCs, dispense into 24-well culture plates at a hematocrit of 2%, and cultured for 41 h.<\/li>\n<li>At 41-h culture, expose the PfRBCs to 5% D-sorbitol (the 2nd exposure), wash, and culture for further 5 h.<\/li>\n<li>At the total 46-h culture, expose the PfRBCs to 5% D-sorbitol (the 3rd exposure).<\/li>\n<li>After the 3rd sorbitol treatment, remove residual schizonts and cell debris by isopycnic density centrifugation for 10 min at 800g on 63% Percoll PLUS* (GE Healthcare Bio-Science Corp., Tokyo, Japan).<\/li>\n<\/ol>\n<p>\u00a0<\/p>\n<p>*3.5 ml 90% Percoll PLUS + 1.5 ml PBS<\/p>\n<p>90% Percoll PLUS is prepared by admixing 100% Percoll PLUS (9 parts) with 1.5 M NaCl (10x physiological saline) (1 part).<\/p>\n<p>\u00a0<\/p>\n<p><strong>Note:<\/strong> Periods for growth to the schizont stage are somewhat variable among strains. Culture periods useful for the protocol should be confirmed beforehand. <\/p>"},"is_project":0},{"component_id":"963707","previous_id":"963706","original_id":"963683","guid":"B8E0BD48B5F44A11A8DA7C31127CB439","previous_guid":"D5C7FA7EB119417A996BB9B06F33ED83","component_type_id":"6","data_id":null,"data":"","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":""},"is_project":0}]}]}